1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | 2C-B |
| brand | String | Nexus, Eroxan (historical, late-1980s through mid-1990s) |
| structure | File | |
| classes | List of String, delimiter: , | Psychedelic • Phenethylamine • 2C-x series |
| mechanism | String | 5-HT2A partial agonist |
| uses | String | |
| starting_dose | String | |
| preparations | String | |
| fda_max | String | |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • insufflated • PR |
| onset | String | 45-75 min (oral) |
| duration | String | 4-8 h |
| halflife | String | Not well characterized |
| bioavailability | String | Not well characterized |
| pregnancy | String | Not established |
| legal | String | [[USLegal:DEA Schedule I|Schedule I]] (United States) |
